Hear from our CEO, Adrian Treverton, about treating non-melanoma skin cancer patients safely during COVID. Patients most likely to develop basal or squamous cell carcinoma are those in the age range at greater risk of serious illness from COVID, so safe and short treatment options are important.
Introducing the SARRP Education Series: Expert Training from Penn Medicine & Xstrahl
Introducing the SARRP Education Series: Expert Training from Penn Medicine & Xstrahl Watch the webinar that officially launched the SARRP Education Series, a new training initiative from Xstrahl designed to help researchers and clinicians get more out of their...




